Background: The effect of personalised mechanical ventilation on clinical outcomes in patients with acute respiratory distress syndrome (ARDS) remains uncertain and needs to be evaluated. We aimed to test whether a mechanical ventilation strategy that was personalised to individual patients' lung morphology would improve the survival of patients with ARDS when compared with standard of care.
Methods: We designed a multicentre, single-blind, stratified, parallel-group, randomised controlled trial enrolling patients with moderate-to-severe ARDS in 20 university or non-university intensive care units in France. Patients older than 18 years with early ARDS for less than 12 h were randomly assigned (1:1) to either the control group or the personalised group using a minimisation algorithm and stratified according to the study site, lung morphology, and duration of mechanical ventilation. Only the patients were masked to allocation. In the control group, patients received a tidal volume of 6 mL/kg per predicted bodyweight and positive end-expiratory pressure (PEEP) was selected according to a low PEEP and fraction of inspired oxygen table, and early prone position was encouraged. In the personalised group, the treatment approach was based on lung morphology; patients with focal ARDS received a tidal volume of 8 mL/kg, low PEEP, and prone position. Patients with non-focal ARDS received a tidal volume of 6 mL/kg, along with recruitment manoeuvres and high PEEP. The primary outcome was 90-day mortality as established by intention-to-treat analysis. This study is registered online with ClinicalTrials.gov, NCT02149589.
Findings: From June 12, 2014, to Feb 2, 2017, 420 patients were randomly assigned to treatment. 11 patients were excluded in the personalised group and nine patients were excluded in the control group; 196 patients in the personalised group and 204 in the control group were included in the analysis. In a multivariate analysis, there was no difference in 90-day mortality between the group treated with personalised ventilation and the control group in the intention-to-treat analysis (hazard ratio [HR] 1·01; 95% CI 0·61-1·66; p=0·98). However, misclassification of patients as having focal or non-focal ARDS by the investigators was observed in 85 (21%) of 400 patients. We found a significant interaction between misclassification and randomised group allocation with respect to the primary outcome (p<0·001). In the subgroup analysis, the 90-day mortality of the misclassified patients was higher in the personalised group (26 [65%] of 40 patients) than in the control group (18 [32%] of 57 patients; HR 2·8; 95% CI 1·5-5·1; p=0·012.
Interpretation: Personalisation of mechanical ventilation did not decrease mortality in patients with ARDS, possibly because of the misclassification of 21% of patients. A ventilator strategy misaligned with lung morphology substantially increases mortality. Whether improvement in ARDS phenotyping can decrease mortality should be assessed in a future clinical trial.
Funding: French Ministry of Health (Programme Hospitalier de Recherche Clinique InterRégional 2013).
Copyright © 2019 Elsevier Ltd. All rights reserved.
Rationale, study design and analysis plan of the lung imaging morphology for ventilator settings in acute respiratory distress syndrome study (LIVE study): Study protocol for a randomised controlled trial.Anaesth Crit Care Pain Med. 2017 Oct;36(5):301-306. doi: 10.1016/j.accpm.2017.02.006. Epub 2017 Mar 18. Anaesth Crit Care Pain Med. 2017. PMID: 28323236
Permissive Hypercapnia, Alveolar Recruitment and Low Airway Pressure (PHARLAP): a protocol for a phase 2 trial in patients with acute respiratory distress syndrome.Crit Care Resusc. 2018 Jun;20(2):139-149. Crit Care Resusc. 2018. PMID: 29852853 Clinical Trial.
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial.Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7. Lancet Respir Med. 2020. PMID: 32043986
Lung recruitment maneuvers in acute respiratory distress syndrome and facilitating resolution.Crit Care Med. 2003 Apr;31(4 Suppl):S265-71. doi: 10.1097/01.CCM.0000057902.29449.29. Crit Care Med. 2003. PMID: 12682451 Review.
Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis.Ann Am Thorac Soc. 2017 Oct;14(Supplement_4):S297-S303. doi: 10.1513/AnnalsATS.201704-338OT. Ann Am Thorac Soc. 2017. PMID: 29043834 Review.
Cited by 8 articles
High versus low PEEP in non-recruitable collapsed lung tissue: possible implications for patients with COVID-19.Lancet Respir Med. 2020 Apr 20:S2213-2600(20)30180-6. doi: 10.1016/S2213-2600(20)30180-6. Online ahead of print. Lancet Respir Med. 2020. PMID: 32325016 Free PMC article. No abstract available.
Potential for Lung Recruitment and Ventilation-Perfusion Mismatch in Patients With the Acute Respiratory Distress Syndrome From Coronavirus Disease 2019.Crit Care Med. 2020 Apr 17:10.1097/CCM.0000000000004386. doi: 10.1097/CCM.0000000000004386. Online ahead of print. Crit Care Med. 2020. PMID: 32317591 Free PMC article.
Emerging concepts in ventilation-induced lung injury.F1000Res. 2020 Mar 31;9:F1000 Faculty Rev-222. doi: 10.12688/f1000research.20576.1. eCollection 2020. F1000Res. 2020. PMID: 32269759 Free PMC article. Review.
ARDS Subphenotypes: Understanding a Heterogeneous Syndrome.Crit Care. 2020 Mar 24;24(1):102. doi: 10.1186/s13054-020-2778-x. Crit Care. 2020. PMID: 32204722 Free PMC article. Review.
Personalized mechanical ventilation for acute respiratory distress syndrome: are we ready?-Maybe.J Thorac Dis. 2019 Dec;11(12):5658-5661. doi: 10.21037/jtd.2019.12.79. J Thorac Dis. 2019. PMID: 32030293 Free PMC article. No abstract available.